SK Capital Partners is a New York-based private equity firm that focuses on mid-market chemicals, specialty materials and healthcare businesses. Within these sectors, the firm is interested in segments such as water treatment and modifiers, shale gas finds in North America, agrochemicals, hospital outsourcing and drug delivery. The firm targets buyout and corporate carve-out transactions. It focuses on leading companies in niche markets which have sustainable competitive advantages.SK Capital Partners is a spin out of Arsenal Capital Partners.
Buyout
7 funds found in our dataset.
Focus on specialty materials, ingredients, and life sciences companies with potential for sustainability and operational improvements
North America, Europe, Asia
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.